rs779777625
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2
The NM_001134363.3(RBM20):c.613C>A(p.Gln205Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000087 in 1,551,598 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001134363.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBM20 | NM_001134363.3 | c.613C>A | p.Gln205Lys | missense_variant | Exon 2 of 14 | ENST00000369519.4 | NP_001127835.2 | |
RBM20 | XM_017016103.3 | c.448C>A | p.Gln150Lys | missense_variant | Exon 2 of 14 | XP_016871592.1 | ||
RBM20 | XM_017016104.3 | c.229C>A | p.Gln77Lys | missense_variant | Exon 2 of 14 | XP_016871593.1 | ||
RBM20 | XM_047425116.1 | c.229C>A | p.Gln77Lys | missense_variant | Exon 2 of 14 | XP_047281072.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152252Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000519 AC: 8AN: 154100Hom.: 0 AF XY: 0.0000122 AC XY: 1AN XY: 81832
GnomAD4 exome AF: 0.0000922 AC: 129AN: 1399346Hom.: 0 Cov.: 32 AF XY: 0.0000768 AC XY: 53AN XY: 690180
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152252Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74372
ClinVar
Submissions by phenotype
not provided Uncertain:2
Has not been previously published as pathogenic or benign to our knowledge; In silico analysis indicates that this missense variant does not alter protein structure/function -
- -
Dilated cardiomyopathy 1DD Uncertain:1Benign:1
- -
- -
Cardiovascular phenotype Uncertain:1
The p.Q205K variant (also known as c.613C>A), located in coding exon 2 of the RBM20 gene, results from a C to A substitution at nucleotide position 613. The glutamine at codon 205 is replaced by lysine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at